AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Investor Alert: Lawsuit Against CEO and Other Officers Filed
An investor who currently holds shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) filed a lawsuit against the CEO of AVEO Pharmaceuticals, Inc. and seven other officers over alleged breaches of fiduciary duties in connection with AVEO Pharmaceuticals’ drug Tivopath or tivozanib.
View full press release